Dai-ichi Karkaria Limited reported a significant turnaround in profitability for the first quarter of FY27, with standalone net profit rising to ₹6.09 crore from a net loss of ₹2.19 crore in Q1FY26. The Mumbai-based specialty chemicals manufacturer saw its revenue from operations expand by 46.6% year-on-year to ₹57.84 crore, driven by higher operational volumes and improved pricing dynamics.

The Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, at a meeting held on August 13, 2026. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, B S R & Co. LLP.

Financial Performance

On a consolidated basis, the group recorded a net profit of ₹2.93 crore for the quarter, compared to a negligible profit of ₹0.02 crore in the same period last year. This improvement was bolstered by a share of profit from joint ventures amounting to ₹0.89 crore, up from ₹0.53 crore in Q1FY26.

Revenue growth outpaced expense inflation, with total expenses rising 34.0% year-on-year to ₹54.85 crore. Cost of materials consumed increased to ₹40.30 crore from ₹31.75 crore, while employee benefits expenses rose modestly to ₹7.14 crore from ₹6.49 crore.

What the Numbers Show

A key driver of the bottom-line improvement was the surge in other income, which jumped 57.9% year-on-year to ₹5.51 crore. In Q1FY27, other income constituted approximately 8.7% of total income, compared to 8.1% in the prior year, indicating that non-operational gains contributed meaningfully to the top-line expansion alongside core business growth.

The company operates in a single reportable segment: Specialty Chemicals. There were no exceptional items recorded in the current quarter. For the previous full fiscal year (FY26), the company had accounted for a one-time impact of ₹20 lakh related to new labour codes as an exceptional item.

Earnings per share (EPS) on a standalone basis stood at ₹8.18, a significant improvement from the loss of ₹2.94 per share in Q1FY26. On a consolidated basis, EPS was ₹3.93 against ₹0.03 in the corresponding quarter of the previous year.

dai-ichi karkaria reported a standalone net loss of ₹54 lakh for the financial year ended March 31, 2026 (FY26), marking a significant reversal from the net profit of ₹618 lakh recorded in FY25. The decline was primarily driven by an 11% drop in revenue from operations to ₹1,613 crore, reflecting softer demand and competitive pricing pressures in the specialty chemicals sector. This result signals a challenging operating environment for the company as it navigates global trade disruptions and raw material volatility.

The Board of Directors recommended a final dividend of ₹1.50 per equity share, amounting to a total payout of ₹111.77 lakhs, subject to shareholder approval at the 66th Annual General Meeting scheduled for August 27, 2026. The meeting will also address the re-appointment of Mrs. Shernaz Vakil, who retires by rotation, and seek ratification for the remuneration of M/s. Diwanji & Associates as Cost Auditors for FY27.

Financial Performance

Revenue from operations stood at ₹16,130 lakh in FY26, down from ₹18,138 lakh in FY25. Other income increased to ₹735 lakh from ₹446 lakh, largely due to higher dividend income from its joint venture, ChampionX Dai-ichi India Private Limited (CXDI). However, this was insufficient to offset the decline in operational profitability. Profit before tax swung to a loss of ₹47 lakh from a profit of ₹847 lakh in the prior year.

The company recorded an exceptional item charge of ₹20 lakh related to the one-time impact of new Labour Codes notified by the Government of India. In contrast, FY25 included an exceptional gain of ₹153 lakh from the sale of tenancy rights, which significantly boosted prior-year profits.

Operational Highlights

Despite the headwinds, management highlighted progress in strengthening manufacturing capabilities. A key milestone was the expansion of ethoxylation capacity through the addition of a new EO reactor at the Dahej facility. This investment aims to enhance operational flexibility and serve a wider range of specialty chemical applications. The Dahej facility achieved record production levels across several product categories during the year.

Innovation remained central to the growth strategy, with the commissioning of a dedicated Agrochemical Application Laboratory. This facility is expected to accelerate formulation development and reduce time-to-commercialisation for agrochemical products. The Energy and Oilfield Chemicals segment continued to be a strong growth driver, benefiting from increased demand in export markets.

Related Party Transactions

Shareholders will vote on material related party transactions with two entities: ChampionX Dai-ichi India Private Limited (CXDI) and Indian Oxides and Chemicals Private Limited (IOCL). The company seeks approval for transactions up to ₹60 crore each with these entities over the next fifteen months. These transactions involve the sale and purchase of goods and services, executed at arm’s length basis. CXDI is a joint venture with CTI Chemicals Asia Pacific Pte. Ltd., while IOCL is a related party where Mrs. Shernaz Vakil holds directorship.

What the Numbers Show

The divergence between the decline in revenue and the increase in other income highlights a shift in profit drivers. While core operational profitability contracted due to lower volumes and pricing pressure, non-operating income from the joint venture provided a partial buffer. The absence of the large exceptional gain from FY25 further accentuates the year-on-year decline in net profit. Investors should monitor whether the capacity expansions, particularly in ethoxylation, can drive volume growth and margin recovery in FY27.